Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2025-12-25 @ 1:25 PM
NCT ID: NCT01656759
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT01656759
Study Brief: Use of a Novel Fibrin Sealant in Total Knee Arthroplasty
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Control Group Control group. Will not receive the fibrin spray. None None 0 27 0 27 View
Treatment Group--Evicel Fibrin Spray Patient will receive the fibrin spray after implantation of device but before the wound is closed. Patients will be randomized to receive spray or not and postop parameters measured. Evicel Fibrin Spray: 10cc syringe dose, once at the end of TKA None None 0 25 0 25 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Pulmonary Embolism None Respiratory, thoracic and mediastinal disorders None View
Deep Vein Thrombosis None Blood and lymphatic system disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Superficial Wound Dehiscence None Skin and subcutaneous tissue disorders None View